跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Wilomax - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Wilomax
Approved
STANDARD
Wilomax
Hizon Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
30401c5ba44c46a9
Company
Hizon Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
30401c5ba44c46a9
Drug Approval Philippines Name
Wilomax
Product Name
Wilomax
Registration Number
DRP-1334-02
Brand Name
Wilomax
Generic Name
Amlodipine (as besilate)
Dosage Form
Tablet
Dosage Strength
10 mg
Manufacturer
Hizon Laboratories, Inc.
Distributor
Willore Pharma Corporation
Issuance Date
29 December 2023
Expiry Date
05 February 2029
Pharmacologic Category
Calcium Channel Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
30401c5ba44c46a9
Type
Standard
Back to Philippines FDA Approvals